SCOPUS 정보 검색 플랫폼

Bulletin of Experimental Biology and Medicine

Volumn 149, Issue 3, 2010, Pages 347-350

Urokinase and tissue plasminogen activators and their PAI-1 inhibitor in tumors of patients with oral mucosal cancer: Relationship with the main clinical morphological factors

(4) Gershtein, E S a Batsev, A F a Matyakin, E G a Kushlinskii, N E a

a N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER (Russian Federation)

Author keywords

cancer of the oral mucosa; plasminogen activator inhibitor 1; tissue plasminogen activator; urokinase plasminogen activator

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER MORPHOLOGY; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIATION; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN TISSUE; MALE; METASTASIS; MOUTH CANCER; MOUTH MUCOSA; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; HUMANS; IMMUNOENZYME TECHNIQUES; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASMS, SQUAMOUS CELL; PLASMINOGEN ACTIVATOR INHIBITOR 1; RUSSIA; STATISTICS, NONPARAMETRIC; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 77956189457 PISSN: 00074888 EISSN: None Source Type: Journal
DOI: 10.1007/s10517-010-0943-y Document Type: Article

Times cited : (2)

References (15)

1
- 0034874279
- 10.1023/A:1017542915662
- ES Gershtein NE Kushlinskii 2001 Byull. Eksp. Biol. Med. 131 1 81 87 10.1023/A:1017542915662
- (2001) Byull. Eksp. Biol. Med. , vol.131 , Issue.1 , pp. 81-87
- Gershtein, E.S.¹ Kushlinskii, N.E.²

2
- 74949119676
- E. S. Gershtein, Sh. Zh. Talaeva, M. N. Sandybaev, and N. E. Kushlinskii, Mol. Med., No. 1, 4-8 (2007).
- (2007) Mol. Med. , Issue.1 , pp. 4-8
- Gershtein, E.S.¹ Zh. Talaeva, S.² Sandybaev, M.N.³ Kushlinskii, N.E.⁴

3
- 51049109010
- 10.1186/1471-2407-8-220 18673553
- R Bacchiocchi C Rubini E Pierpaoli, et al. 2008 BMC Cancer 8 220 10.1186/1471-2407-8-220 18673553
- (2008) BMC Cancer , vol.8 , pp. 220
- Bacchiocchi, R.¹ Rubini, C.² Pierpaoli, E.³

4
- 35848940540
- 10.1016/j.bjoms.2007.04.021 1:STN:280:DC%2BD2snmvVClsw%3D%3D 17590247
- EA Baker DJ Leaper JP Hayter AJ Dickenson 2007 Br. J. Oral Maxillofac. Surg. 45 8 623 627 10.1016/j.bjoms.2007.04.021 1:STN:280:DC%2BD2snmvVClsw%3D%3D 17590247
- (2007) Br. J. Oral Maxillofac. Surg. , vol.45 , Issue.8 , pp. 623-627
- Baker, E.A.¹ Leaper, D.J.² Hayter, J.P.³ Dickenson, A.J.⁴

5
- 0347917028
- 10.2174/1381612043453559 1:CAS:528:DC%2BD2cXmsVyhsQ%3D%3D 14754404
- MJ Duffy 2004 Curr. Pharm. Des. 10 1 39 49 10.2174/1381612043453559 1:CAS:528:DC%2BD2cXmsVyhsQ%3D%3D 14754404
- (2004) Curr. Pharm. Des. , vol.10 , Issue.1 , pp. 39-49
- Duffy, M.J.¹

6
- 3042685205
- 10.1016/j.clinbiochem.2004.05.013 1:CAS:528:DC%2BD2cXltl2gtb4%3D 15234235
- MJ Duffy C Duggan 2004 Clin. Biochem. 37 7 541 548 10.1016/j.clinbiochem. 2004.05.013 1:CAS:528:DC%2BD2cXltl2gtb4%3D 15234235
- (2004) Clin. Biochem. , vol.37 , Issue.7 , pp. 541-548
- Duffy, M.J.¹ Duggan, C.²

7
- 77956182214
- Use of uPA and PAI-1 to Personalize Therapy in Patients with Breast Cancer
- ISOBM 2009. Amsterdam, September 27-30, 2009
- N. Harbeck, Use of uPA and PAI-1 to Personalize Therapy in Patients with Breast Cancer. International Society of Oncology and Biomarkers 37th Meeting Biomarkers and New Treatment Strategies in Oncology (ISOBM 2009. Amsterdam, September 27-30, 2009), (2009), p. 114.
- (2009) International Society of Oncology and Biomarkers 37th Meeting Biomarkers and New Treatment Strategies in Oncology , pp. 114
- Harbeck, N.¹

8
- 18144427905
- 15878520
- B Hundsdorfer HF Zeilhofer KP Bock, et al. 2005 J. Craniomaxillofac. Surg. 33 3 191 196 15878520
- (2005) J. Craniomaxillofac. Surg. , vol.33 , Issue.3 , pp. 191-196
- Hundsdorfer, B.¹ Zeilhofer, H.F.² Bock, K.P.³

9
- 0031921285
- 10.1016/S1368-8375(97)00028-6 1:CAS:528:DyaK1cXjsleltL0%3D 9659521
- S Nozaki Y Endo S Kawashiri, et al. 1998 Oral Oncol. 34 1 58 62 10.1016/S1368-8375(97)00028-6 1:CAS:528:DyaK1cXjsleltL0%3D 9659521
- (1998) Oral Oncol. , vol.34 , Issue.1 , pp. 58-62
- Nozaki, S.¹ Endo, Y.² Kawashiri, S.³

10
- 26444486892
- 1:CAS:528:DC%2BD2MXhtFShsrnL
- S Nozaki Y Endo H Nakahara, et al. 2005 Ibid. 41 10 971 977 1:CAS:528:DC%2BD2MXhtFShsrnL
- (2005) Oral Oncol. , vol.41 , Issue.10 , pp. 971-977
- Nozaki, S.¹ Endo, Y.² Nakahara, H.³

11
- 35048812952
- 10.1042/BJ20071037 1:CAS:528:DC%2BD2sXhtVyrtr%2FF 17880283
- Z Shi MS Stack 2007 Biochem. J. 407 2 153 159 10.1042/BJ20071037 1:CAS:528:DC%2BD2sXhtVyrtr%2FF 17880283
- (2007) Biochem. J. , vol.407 , Issue.2 , pp. 153-159
- Shi, Z.¹ Stack, M.S.²

12
- 34247261470
- 10.1002/hed.20527 17163465
- L Speleman JD Kerrebijn MP Look, et al. 2007 Head Neck 29 4 341 350 10.1002/hed.20527 17163465
- (2007) Head Neck , vol.29 , Issue.4 , pp. 341-350
- Speleman, L.¹ Kerrebijn, J.D.² Look, M.P.³

13
- 0034532067
- 1:CAS:528:DC%2BD3cXovVKitrk%3D 11268487
- P Strojan M Budihna L Smid, et al. 2000 Anticancer Res. 20 5C 3975 3981 1:CAS:528:DC%2BD3cXovVKitrk%3D 11268487
- (2000) Anticancer Res. , vol.20 , Issue.5 C , pp. 3975-3981
- Strojan, P.¹ Budihna, M.² Smid, L.³

14
- 38649137301
- 10.1016/j.archoralbio.2007.09.001 1:CAS:528:DC%2BD1cXhsVSmsb8%3D 17936716
- SF Yang WE Yang WH Kuo, et al. 2008 Arch. Oral Biol. 53 3 287 294 10.1016/j.archoralbio.2007.09.001 1:CAS:528:DC%2BD1cXhsVSmsb8%3D 17936716
- (2008) Arch. Oral Biol. , vol.53 , Issue.3 , pp. 287-294
- Yang, S.F.¹ Yang, W.E.² Kuo, W.H.³

15
- 67449102220
- 10.1002/ijc.24360 1:CAS:528:DC%2BD1MXms1amurk%3D 19391133
- H Zhou Y Tang X Liang, et al. 2009 Int. J. Cancer 125 2 453 462 10.1002/ijc.24360 1:CAS:528:DC%2BD1MXms1amurk%3D 19391133
- (2009) Int. J. Cancer , vol.125 , Issue.2 , pp. 453-462
- Zhou, H.¹ Tang, Y.² Liang, X.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.